Nucleotide sequence of the 3' terminus of E. coli 16S ribosomal RNA

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.

Frontiers in pharmacology·2024

On demand delivery and analysis of single molecules on a programmable nanopore-optofluidic device.

Nature communications·2019

Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.

Annals of hematology·2019

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019

Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.

Medical oncology (Northwood, London, England)·2017

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.

Leukemia·2017

The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond.

Molecular biology reports·2026

Protective effects of Bacillus clausii in cyclophosphamide-induced immunosuppression and intestinal mucositis in rats: histopathological and inflammatory evaluation.

Molecular biology reports·2026

NHSL3 knockout modulates sorafenib response, growth, and motility in hepatocellular carcinoma cell models.

Molecular biology reports·2026

Mitochondrial metabolite transporters at the crossroads of metabolic reprogramming, epigenetic regulation and therapeutic vulnerabilities in colorectal cancer.

Molecular biology reports·2026

LncRNA Loc646329 modulates Alzheimer's disease-related phenotypes through the miR-150/WNT/β-catenin axis in cellular and APP/PS1 mouse models.

Molecular biology reports·2026

CRISPR-Cas9 genome editing: technological advances, delivery strategies and precision engineering of primary cells for therapeutic application in genetic disorders and diabetes mellitus.

Molecular biology reports·2026

Regulatory roles of G-quadruplexes and G-quadruplex-binding proteins across the enhancer and promoter of the HBV genome.

Virology journal·2026

In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity.

Science immunology·2026

Telomeres in mitosis: organization and dynamics.

Nucleus (Austin, Tex.)·2026

Production of MarathonRT and its comparison with commercial reverse transcriptases for tRNA sequencing library preparation.

RNA biology·2026

Transcription and Three-Dimensional Genome Organization: Cause, Consequence, or Coordination?

BioEssays : news and reviews in molecular, cellular and developmental biology·2026

AI-assisted Cryo-ET workflow for 3D visualization of chromatin during cellular differentiation.

Biochemistry and biophysics reports·2026

Related Experiment Videos

Nucleotide sequence of the 3' terminus of E. coli 16S ribosomal RNA

Related Concept Videos

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.

On demand delivery and analysis of single molecules on a programmable nanopore-optofluidic device.

Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.

The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond.

Protective effects of Bacillus clausii in cyclophosphamide-induced immunosuppression and intestinal mucositis in rats: histopathological and inflammatory evaluation.

NHSL3 knockout modulates sorafenib response, growth, and motility in hepatocellular carcinoma cell models.

Mitochondrial metabolite transporters at the crossroads of metabolic reprogramming, epigenetic regulation and therapeutic vulnerabilities in colorectal cancer.

LncRNA Loc646329 modulates Alzheimer's disease-related phenotypes through the miR-150/WNT/β-catenin axis in cellular and APP/PS1 mouse models.

CRISPR-Cas9 genome editing: technological advances, delivery strategies and precision engineering of primary cells for therapeutic application in genetic disorders and diabetes mellitus.

Regulatory roles of G-quadruplexes and G-quadruplex-binding proteins across the enhancer and promoter of the HBV genome.

In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity.

Telomeres in mitosis: organization and dynamics.

Production of MarathonRT and its comparison with commercial reverse transcriptases for tRNA sequencing library preparation.

Transcription and Three-Dimensional Genome Organization: Cause, Consequence, or Coordination?

AI-assisted Cryo-ET workflow for 3D visualization of chromatin during cellular differentiation.

Related Experiment Videos

Nucleotide sequence of the 3' terminus of E. coli 16S ribosomal RNA

Related Concept Videos

Related Articles